ClinicalTrials.Veeva

Menu

Pupillary Response After Glaucoma Medication (pupil)

G

Glostrup University Hospital, Copenhagen

Status

Completed

Conditions

Drug Effect (Glaucoma Drugs)

Treatments

Drug: Latanoprost
Drug: Timolol
Drug: Dorzolamide

Study type

Interventional

Funder types

Other

Identifiers

NCT02522039
GlostrupUH

Details and patient eligibility

About

Investigation of the effect on the pupillary constriction by latanoprost, dorzolamide,timolol in healthy subjects. The pupillary constriction is compared to no drug.

Enrollment

21 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy subjects

Exclusion criteria

  • ophthalmological diseases
  • systemic disease
  • smoking
  • refractive error >= 6 diopters

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

21 participants in 4 patient groups

Latanoprost
Experimental group
Description:
solution, 1 drop of 50ug/ml latanoprost, was given to study eye after washout period of 1 week between drugs
Treatment:
Drug: Latanoprost
Timolol
Experimental group
Description:
solution, 1 drop of 5mg/ml timolol , was given to study eye after washout period of 1 week between drugs
Treatment:
Drug: Timolol
dorzolamide
Experimental group
Description:
solution, 1 drop of 20 mg/ml dorzolamide, was given to study eye after washout period of 1 week between drugs
Treatment:
Drug: Dorzolamide
Other
No Intervention group
Description:
no drug given and pupil measurements were performed before and at 30 and 180 min at equivalent hours as drugs measurements

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems